leadf
logo-loader
viewNovavax, Inc.

Novavax to present on COVID-19 vaccine candidate this week

The company is attending the 2020 World Vaccine Congress Washington scheduled for this week

Novavax, Inc. - Novavax to present on COVID-19 vaccine candidate this week

Novavax Inc (NASDAQ:NVAX) announced it will present on its lead COVID-19 vaccine candidate at the 2020 World Vaccine Congress Washington scheduled for this week.

It will also present its influenza and respiratory syncytial virus jabs, while the main focus will be to share expertise and the latest research related to the pandemic and vaccine development to address global health.

READ: Novavax to start late-stage trials for COVID-19 vaccine in UK

The US firm is set to start late-stage trials for NVX-CoV2373 in the UK, enrolling up to 10,000 participants aged 18-84 over the next six weeks, with half receiving the formulation and half receiving a placebo.

Up to 400 volunteers will receive both Novavax’s candidate and a seasonal flu vaccine to see if the combination works.

Data for from the Phase II of clinical trials are expected in the fourth quarter of 2020.

There are five pharma giants currently at the latest stage of trials for their COVID-19 vaccine candidates: Novavax, Johnson & Johnson, AstraZeneca, Pfizer and Moderna.

J&J said last week a single dose of its formulation produced a strong immune response in phase II of trials.

Quick facts: Novavax, Inc.

Price: 80.71 USD

NASDAQ:NVAX
Market: NASDAQ
Market Cap: $4.95 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Purepoint Uranium Group sees great opportunity as they look to develop in...

Purepoint Uranium Group (CVE: PTU) President and CEO Chris Frostad joined Steve Darling from Proactive to shared details about the company that is focused on the exploration of its projects in the Canadian Athabasca Basin, the world’s richest uranium region. Frostad telling Proactive about...

9 hours, 4 minutes ago

2 min read